Inventor · disambiguated record
Lori Payton
Also filed as: PAYTON LORI
3 granted patents·4 pending applications·5 citations·filing 2018–2025
55Inventor score
Files withALEXION PHARMA INC7
Top patents by PatentIndex Score
7 records- 0188US12128101B2Dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS)ALEXION PHARMA INC·Filed 2018·Granted Oct 29, 2024·5 cites·12 claims
- 0276US2025127892A1Dosage and administration of anti-c5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (pnh) and atypical hemolytic uremic syndrome (ahus)ALEXION PHARMA INC·Filed 2024·Application pending·0 cites
- 0363US2025144208A1Dosage and administration of anti-c5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (pnh) and atypical hemolytic uremic syndrome (ahus)ALEXION PHARMA INC·Filed 2025·Application pending·0 cites
- 0448US2023235035A1Dosage and administration of anti-c5 antibodies for treating paroxysmal nocturnal hemoglobinuria (pnh) in pediatric patientsALEXION PHARMA INC·Filed 2021·Application pending·0 cites
- 0543US12404320B2Dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH) in pediatric patientsALEXION PHARMA INC·Filed 2019·Granted Sep 2, 2025·0 cites·12 claims
- 0642US12460012B2Dosage and administration of anti-C5 antibodies for treatment of atypical hemolytic uremic syndrome (aHUS) in pediatric patientsALEXION PHARMA INC·Filed 2019·Granted Nov 4, 2025·0 cites·15 claims
- 0738US2022235121A1Dosage and administration of anti-c5 antibodies for treatment of atypical hemolytic uremic syndrome (ahus)ALEXION PHARMA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lori Payton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →